• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Valeant Pharmaceuticals International

Valeant Pharmaceuticals International

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. UPDATE: Here are the best S&P 500 stocks and sectors of 2014

    UPDATE: Here are the best S&P 500 stocks and sectors of 2014

  2. InSite Vision Announces Date for Annual Stockholder Meeting

    InSite Vision Announces Date for Annual Stockholder Meeting

  3. Research and Markets: Acne Vulgaris - Pipeline Review, H2 2014

    Research and Markets: Acne Vulgaris - Pipeline Review, H2 2014

  4. Research and Markets: Acne Vulgaris - Pipeline Review, H1 2014

    Research and Markets: Acne Vulgaris - Pipeline Review, H1 2014

  5. COTCHETT, PITRE & McCARTHY, LLP Files Class Action Lawsuit on Behalf of Persons Who Sold Allergan Stock Between February 25, 2014 and April 21, 2014

    COTCHETT, PITRE & McCARTHY, LLP Files Class Action Lawsuit on Behalf of Persons Who Sold Allergan Stock Between February 25, 2014 and April 21, 2014

  6. Brent Saunders faces challenge of running combined Actavis-Allergan

    Brent Saunders faces challenge of running combined Actavis-Allergan

  7. Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018

    Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018

  8. Activist Fund ValueAct Capital to Seek Up to $1.5 Billion From Investors -- Update

    Activist Fund ValueAct Capital to Seek Up to $1.5 Billion From Investors -- Update

  9. Ultimate Stock-Pickers: Top Holdings of Top-Performing Managers

    Our Ultimate Stock-Pickers Index continues to beat the market even as relatively few of our top managers are outperforming the S&P 500.

  10. 3 Truths in a Schizo Market

    This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.